IL143717A0 - Utilization of inhibitors of the kqt1 channel in order to produce a medicament for treating diseases which are caused by parasitic helminths and ectoparasites - Google Patents

Utilization of inhibitors of the kqt1 channel in order to produce a medicament for treating diseases which are caused by parasitic helminths and ectoparasites

Info

Publication number
IL143717A0
IL143717A0 IL14371799A IL14371799A IL143717A0 IL 143717 A0 IL143717 A0 IL 143717A0 IL 14371799 A IL14371799 A IL 14371799A IL 14371799 A IL14371799 A IL 14371799A IL 143717 A0 IL143717 A0 IL 143717A0
Authority
IL
Israel
Prior art keywords
ectoparasites
medicament
inhibitors
utilization
caused
Prior art date
Application number
IL14371799A
Other languages
English (en)
Original Assignee
Aventis Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Gmbh filed Critical Aventis Pharma Gmbh
Publication of IL143717A0 publication Critical patent/IL143717A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4433—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with oxygen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/14—Ectoparasiticides, e.g. scabicides

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrane Compounds (AREA)
IL14371799A 1998-12-17 1999-12-07 Utilization of inhibitors of the kqt1 channel in order to produce a medicament for treating diseases which are caused by parasitic helminths and ectoparasites IL143717A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19858253A DE19858253A1 (de) 1998-12-17 1998-12-17 Verwendung von Inhibitoren des KQt1-Kanals zur Herstellung eines Medikaments zur Behandlung von Krankheiten, die durch Helminthen und Ektoparasiten hervorgerufen werden
PCT/EP1999/009547 WO2000035429A1 (de) 1998-12-17 1999-12-07 Verwendung von inhibitoren des kqt1-kanals zur herstellung eines medikaments zur behandlung von krankheiten, die durch helminthen und ektoparasiten hervorgerufen werden

Publications (1)

Publication Number Publication Date
IL143717A0 true IL143717A0 (en) 2002-04-21

Family

ID=7891421

Family Applications (1)

Application Number Title Priority Date Filing Date
IL14371799A IL143717A0 (en) 1998-12-17 1999-12-07 Utilization of inhibitors of the kqt1 channel in order to produce a medicament for treating diseases which are caused by parasitic helminths and ectoparasites

Country Status (24)

Country Link
US (2) US6335363B1 (xx)
EP (1) EP1140042B1 (xx)
JP (1) JP2002532412A (xx)
KR (1) KR20010089574A (xx)
CN (1) CN1170528C (xx)
AR (1) AR021690A1 (xx)
AT (1) ATE390130T1 (xx)
AU (1) AU1559500A (xx)
BR (1) BR9916190A (xx)
CA (1) CA2355300A1 (xx)
CZ (1) CZ20012125A3 (xx)
DE (2) DE19858253A1 (xx)
HK (1) HK1041647B (xx)
HR (1) HRPK20010442B1 (xx)
HU (1) HUP0200152A3 (xx)
IL (1) IL143717A0 (xx)
NO (1) NO20012976L (xx)
NZ (1) NZ512408A (xx)
PL (1) PL349511A1 (xx)
RU (1) RU2238090C2 (xx)
SK (1) SK8562001A3 (xx)
TR (1) TR200101750T2 (xx)
WO (1) WO2000035429A1 (xx)
ZA (1) ZA200103620B (xx)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0417107A (pt) * 2003-12-19 2007-02-06 Genentech Inc fragmento de anticorpo, métodos de preparação do fragmento de anticorpo, ácido nucléico isolado, composições, célula hospedeira e métodos de fabricação e de geração de fragmento de anticorpo
DK1773885T3 (da) * 2004-08-05 2010-08-16 Genentech Inc Humaniserede anti-c-met-antagonister
WO2008154466A2 (en) 2007-06-07 2008-12-18 Divergence, Inc. Control of ectoparasites
US20100307542A1 (en) * 2009-06-05 2010-12-09 Kraft Foods Global Brands Llc Method of Reducing Surface Oil on Encapsulated Material
US8859003B2 (en) * 2009-06-05 2014-10-14 Intercontinental Great Brands Llc Preparation of an enteric release system
US20100310726A1 (en) 2009-06-05 2010-12-09 Kraft Foods Global Brands Llc Novel Preparation of an Enteric Release System
US9968564B2 (en) * 2009-06-05 2018-05-15 Intercontinental Great Brands Llc Delivery of functional compounds
SG194932A1 (en) 2011-06-30 2013-12-30 Genentech Inc Anti-c-met antibody formulations
US8859005B2 (en) 2012-12-03 2014-10-14 Intercontinental Great Brands Llc Enteric delivery of functional ingredients suitable for hot comestible applications
BR112016021383A2 (pt) 2014-03-24 2017-10-03 Genentech Inc Método para identificar um paciente com câncer que é susceptível ou menos susceptível a responder ao tratamento com um antagonista de cmet, método para identificar um paciente apresentando câncer previamente tratado, método para determinar a expressão do biomarcador hgf, antagonista anti-c-met e seu uso, kit de diagnóstico e seu método de preparo
EP2957557A1 (en) * 2014-06-17 2015-12-23 Novartis Tiergesundheit AG New compounds
SG10201913587WA (en) 2016-02-05 2020-02-27 Denali Therapeutics Inc Inhibitors of receptor-interacting protein kinase 1
PL3552017T3 (pl) 2016-12-09 2022-08-08 Denali Therapeutics Inc. Związki użyteczne jako inhibitory RIPK1
EP3615527B1 (en) * 2017-06-30 2024-03-06 Elanco Animal Health GmbH New azaquinoline derivatives
IL314082A (en) 2022-01-12 2024-09-01 Denali Therapeutics Inc Crystal forms of (S)-5-benzyl-N-(5-methyl-4-oxo-2,3,4,5-tetrahydropyrido[3,2-b][1,4]oxazapin-3-yl)- H4- 1,2,4-triazole-3-carboxamide

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2131297T3 (es) * 1993-11-29 1999-07-16 Merrell Pharma Inc Nuevos derivados de bencenosulfonilamina como inhibidores de la accion il-1.
US5559026A (en) * 1994-10-31 1996-09-24 American Cyanamid Company Genes encoding a novel family of potassium channels
DE19504379A1 (de) * 1995-02-10 1996-08-14 Hoechst Ag Substituierte Benzolsulfonylharnstoffe und -thioharnstoffe, Verfahren zu ihrer Herstellung und ihre Verwendung zur Herstellung pharmazeutischer Präparate sowie sie enthaltende pharmazeutische Präparate
NZ314800A (en) * 1996-05-15 1999-02-25 Hoechst Ag Sulphonamide-substituted chroman derivatives and their use as a medicament or a diagnostic
DE19706675A1 (de) 1997-02-20 1998-08-27 Hoechst Ag Sulfonamid-substituierte Chromane, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
DE19707656A1 (de) 1997-02-26 1998-08-27 Hoechst Ag Sulfonamid-substituierte anellierte 7-Ring-Verbindungen, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltende pharmazeutische Zubereitungen
DE19742509A1 (de) 1997-09-26 1999-04-01 Hoechst Marion Roussel De Gmbh Sulfonamid-substituierte Chromane, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltende pharmazeutische Zubereitungen
DE19742508A1 (de) * 1997-09-26 1999-04-01 Hoechst Marion Roussel De Gmbh Sulfonamid-substituierte Chromane, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltende pharmazeutische Zubereitungen
DE19748469A1 (de) * 1997-11-03 1999-05-06 Hoechst Marion Roussel De Gmbh Sulfonamid-substituierte Benzopyranderivate, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament sowie sie enthaltende pharmazeutische Zubereitungen

Also Published As

Publication number Publication date
EP1140042A1 (de) 2001-10-10
EP1140042B1 (de) 2008-03-26
US6335363B1 (en) 2002-01-01
HK1041647A1 (en) 2002-07-19
AR021690A1 (es) 2002-07-31
US20020055537A1 (en) 2002-05-09
HUP0200152A2 (hu) 2002-05-29
CN1330540A (zh) 2002-01-09
DE19858253A1 (de) 2000-06-21
CA2355300A1 (en) 2000-06-22
RU2238090C2 (ru) 2004-10-20
NO20012976L (no) 2001-08-06
HRP20010442A2 (en) 2002-06-30
ZA200103620B (en) 2002-06-04
HK1041647B (zh) 2005-04-01
AU1559500A (en) 2000-07-03
NZ512408A (en) 2003-10-31
DE59914712D1 (de) 2008-05-08
CZ20012125A3 (cs) 2001-09-12
HUP0200152A3 (en) 2003-01-28
SK8562001A3 (en) 2001-12-03
WO2000035429A1 (de) 2000-06-22
ATE390130T1 (de) 2008-04-15
KR20010089574A (ko) 2001-10-06
JP2002532412A (ja) 2002-10-02
NO20012976D0 (no) 2001-06-15
CN1170528C (zh) 2004-10-13
HRPK20010442B1 (en) 2003-10-31
PL349511A1 (en) 2002-07-29
TR200101750T2 (tr) 2002-01-21
BR9916190A (pt) 2001-09-11

Similar Documents

Publication Publication Date Title
HRPK20010442B1 (en) Utilization of inhibitors of the kqt1 channel in order to produce a medicament for treating diseases which are caused by parasitic helminths and ectoparasites
ID25824A (id) Formulasi terapeutik untuk memberikan tolterodin dengan pelepasan yang terkendali
DK2052714T3 (da) Topisk gel-fremføringssystem til behandling af hudlidelser
DK1268481T3 (da) Inaseinkibitorer som terapeutiske midler
BR9707425A (pt) Composto processo terapêutico para inibir o crescimento de células cancerosas e processo para utilizar o composto
GB9803084D0 (en) Improvements relating to medical injection devices
EE04390B1 (et) Paikne preparaat dermatoloogiliste seisundite raviks
HK1089364A1 (en) Topical compositions and methods for treating pain
DK0925022T3 (da) Forbedringer med relation til hudprikkenåle
ATE436065T1 (de) Interaktives wettsystem zum wetten nach kriterien
IL153574A0 (en) Methods of treating neutrophil-related diseases with topical anesthetics
IS6575A (is) Hýdroxýfenýl-píperidín-4-ýlíden-metýl-bensamíðafleiður til að meðhöndla sársauka
NO20011403D0 (no) Terapi for Õ forbedre kongestion
HK1039555A1 (en) Device for targeted topical treatment of disease
ATE232378T1 (de) Reinigungspflaster zur verbesserung des hautzustandes
PL339836A1 (en) Phtalazine compounds and therapeutic agents suitable to treat erection disorders
ID29792A (id) Formulasi lepas terkendali untuk mengobati corp
ZA978400B (en) Use of inhibitors of the activity of retinoic acid to promote healing.
ID27214A (id) Triazolopiridina untuk pengobatan gangguan trombosis
IS6574A (is) Kínólinýl-píperidín-4-ýlíden-metýl-bensamíðafleiður til að meðhöndla sársauka
IL138601A0 (en) Pyrrolidines as inhibitors of neuraminidases
GB2343844A8 (en) Topical therapeutic composition comprising an enzyme
ITMI980333U1 (it) Struttura perfezionata di suola adatta alla traspirazione
IL141056A0 (en) Protease inhibitors for use in the treatment of psoriasis
AU2001282551A1 (en) Heart muscular cell apoptosis inhibitors and remedies/preventives for heart diseases

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees